
PR EXPERTS FOR
B2B TECHNOLOGY
CLIENTS IN THE NEWS
Xray Launches AI-Powered, Human-Guided Test Capabilities with Sembi IQ
In a recent article in The AI Journal, Xray introduced Jira-native AI for test case and model generation powered by Sembi IQ that keeps humans in the loop for review and governance. The coverage highlights enterprise controls, data privacy, and faster paths from requirement to release.
How Swift’s blockchain could boost bank stablecoins
Stablecoins are edging closer to mainstream banking rails as Swift builds a shared-ledger network with major banks to enable tokenized settlements. In a recent American Banker article, the network’s design around ISO 20022 data standards and broad bank participation is framed as a way to bring programmability and always-on settlement into traditional finance.
Clinical Intelligence Company Cohere Health Announces Acquisition of ZignaAI
Cohere Health is expanding its clinical intelligence capabilities with the acquisition of ZignaAI and the launch of a Payment Integrity suite built for near real-time clinical and coding validation. A recent Forbes article highlights how the move aims to bring more transparency to claims oversight and shift reviews upstream to reduce friction between payers and providers.
Motive, Fleetio Expand Partnership
To help fleets cut manual work around fuel and maintenance, Motive and Fleetio have deepened their integration to centralize fuel, maintenance, and telematics data. In coverage from Transport Topics, the companies point to new two-way syncs that streamline compliance, sharpen visibility, and give operators a clearer view of fuel and service spend.
Collaborative Innovation in CDMOs: Dave Miller, PhD, on Early Engagement, IP Strategy, and Advanced Formulation
AustinPx CSO Dave Miller, PhD, uses a recent BioPharm International conversation to spotlight earlier sponsor engagement, lifecycle-minded IP strategy, and high-science platforms like KinetiSol as pillars of “true co-development.” He positions modern CDMO partnerships as extensions of the sponsor team, from early design decisions through commercialization.
401(k) plans rife with overpriced, underperforming investment options, study finds
In a recent Pensions & Investments article, a new analysis highlights widespread “clunker” funds in corporate 401(k)s—costly options that trail cheaper alternatives and erode participant outcomes. The coverage notes that the review spanned tens of thousands of plans and urges sponsors to replace underperformers with lower-fee choices.









